BALYASNY ASSET MANAGEMENT LLC 13D and 13G filings for Leap Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 06:22 am Sale |
2024-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
BALYASNY ASSET MANAGEMENT LLC | 0 0.000% |
-3,085,104 (Position Closed) |
Filing |
| 2024-11-14 06:07 am Purchase |
2024-09-30 | 13G | Leap Therapeutics, Inc. LPTX |
BALYASNY ASSET MANAGEMENT LLC | 3,085,104 8.060% |
3,085,104 (New Position) |
Filing |